Equifax (EFX) announced a strategic partnership with Ataeva to launch the Ataeva Product Suite. This high-impact, diagnostic toolkit is designed to significantly enhance financial institutions’ ability to accurately value potential customers and optimize portfolio performance, driving profitable growth. The collaboration introduces two market-validated solutions-Ataeva TAPS and Ataeva CYM powered by Equifax consumer credit data. The Ataeva Product Suite utilizes a set of more than 100 FCRA-regulated attributes1 to provide the proprietary metrics essential for identifying true revenue potential and maximizing return on investment (ROI) for credit issuers. Built on up to 12 months of trended data, these solutions allow financial institutions to build highly profitable portfolios of low-risk revolvers and high spenders, establishing a powerful competitive advantage.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EFX:
- Equifax price target lowered to $220 from $245 at UBS
- Equifax price target lowered to $245 from $250 at Baird
- Equifax: Operational Outperformance and Disciplined Buybacks Support Reaffirmed Buy Rating Despite Macro Uncertainty
- Equifax price target lowered to $230 from $240 at Wells Fargo
- Equifax price target raised to $205 from $191 at Clear Street
